Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA.
Lenderink T, Boersma E, Heeschen C, Vahanian A, de Boer MJ, Umans V, van den Brand MJ, Hamm CW, Simoons ML; CAPTURE Investigators. Lenderink T, et al. Among authors: heeschen c. Eur Heart J. 2003 Jan;24(1):77-85. doi: 10.1016/s0195-668x(02)00322-6. Eur Heart J. 2003. PMID: 12559939 Clinical Trial.
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome.
Oemrawsingh RM, Lenderink T, Akkerhuis KM, Heeschen C, Baldus S, Fichtlscherer S, Hamm CW, Simoons ML, Boersma E; CAPTURE investigators. Oemrawsingh RM, et al. Among authors: heeschen c. Heart. 2011 Jul;97(13):1061-6. doi: 10.1136/hrt.2010.197392. Epub 2011 May 10. Heart. 2011. PMID: 21558475
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.
Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, Rutsch W, Berger J, Kootstra J, Simoons ML. Hamm CW, et al. Among authors: heeschen c. N Engl J Med. 1999 May 27;340(21):1623-9. doi: 10.1056/NEJM199905273402103. N Engl J Med. 1999. PMID: 10341274 Free article. Clinical Trial.
Soluble CD40 ligand in acute coronary syndromes.
Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML; CAPTURE Study Investigators. Heeschen C, et al. N Engl J Med. 2003 Mar 20;348(12):1104-11. doi: 10.1056/NEJMoa022600. N Engl J Med. 2003. PMID: 12646667 Free article. Clinical Trial.
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Münzel T, Simoons ML, Hamm CW; CAPTURE Investigators. Baldus S, et al. Among authors: heeschen c. Circulation. 2003 Sep 23;108(12):1440-5. doi: 10.1161/01.CIR.0000090690.67322.51. Epub 2003 Sep 2. Circulation. 2003. PMID: 12952835 Free article.
155 results